Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL3822487 | 0.88 | TSHR (0.32) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3271235 | 0.85 | TSHR (0.36) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Potassium Ion SCHEMBL6053281 | 0.80 | CA1 (0.31) | — | |
| SCHEMBL3272096 | 0.80 | — | — | |
| SCHEMBL31651036 | 0.78 | CA2 (0.36) | — | |
| SCHEMBL31651035 | 0.78 | CA2 (0.36) | — | |
| SCHEMBL31651037 | 0.78 | CA2 (0.36) | — | |
| Perflubutane SCHEMBL1490719 | 0.78 | TSHR (0.53) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3813154 | 0.77 | TSHR (0.36) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1183170 | 0.75 | TSHR (0.50) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7202379-B2 | Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof | MERCK PATENT GMBH (DE) | 2007-04-10 | — | — | US | disclosed |
| US-20050256334-A1 | Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof | MERCK PATENT GMBH (DE) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256334-A1 | Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof | PFAS, PFKFB1, PFKFB4 | TSHR 473/4885NFKB1 3419/4885KCNA1 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.